AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer, is seeking a Clinical Scientist to help advance the use of CAR T therapy for solid tumors. As part of the clinical development [...]
NATICK, Mass. (SEPTEMBER 29, 2022) – AffyImmune Therapeutics, Inc., a clinical stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment of solid cancers, announced today that serial biotech entrepreneur Robert Forrester has been appointed to its Board of Directors. Mr. Forrester’s biotech experience [...]
AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on creating technologies that expand the utility and improve the safety of cell-based immunotherapy for cancer, is seeking an Associate Director, Clinical Biomarkers and CDx (Director, depending on experience) to develop and commercialize companion diagnostic (CDx) tests to support programs in various [...]